Organon & Co. (NYSE:OGN) Downgraded by Zacks Investment Research to Sell

Organon & Co.} stock has undergone multiple analysts rating changes in the recent past.  Organon & Co. Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Organon & Co. (NYSE:OGN) Downgraded by Zacks Investment Research to Sell